Servier Stumbles in Muscle Disease as Drug From $1.5B Deal Fails Pivotal Test
Servier’s sevasemten got here from the acquisition of the muscular dystrophy belongings of Edgewise Therapeutics. Whereas the small molecule had ...
Servier’s sevasemten got here from the acquisition of the muscular dystrophy belongings of Edgewise Therapeutics. Whereas the small molecule had ...
PureTech Well being spinout Celea Therapeutics will apply the financing towards a Section 3 check of its idiopathic pulmonary (IPF) ...
Revolutions Medicines’ daraxonrasib met the principle objectives of its Section 3 take a look at in pancreatic most cancers, posting ...
Ampreloxetine’s Section 3 failure in a number of system atrophy is the third disappointing medical trial end result for the ...
Flagship Pioneering-founded Generate Biomedicines goals to supply much less frequent injections in comparison with a blockbuster bronchial asthma drug from ...
ATLANTA — CDC researchers are being forced to skip a pivotal conference on infectious disease this week due to the government ...
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign ...
A Bristol Myers Squibb drug whose landmark FDA approval introduced the first novel mechanism for treating schizophrenia in decades has ...
MeiraGTx has one gene therapy in a potentially pivotal clinical trial for cancer patients and another gene therapy ready to ...
A depression drug candidate that’s a key part of Johnson & Johnson’s neuroscience strategy has failed a Phase 3 clinical ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.